OCT Biomarkers and Visual Acuity in the Treatment of Diabetic Macular Edema

Ophthalmol Retina. 2024 Mar 19:S2468-6530(24)00120-9. doi: 10.1016/j.oret.2024.03.016. Online ahead of print.

¹ New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
² New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
³ New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts. Electronic address: nadiakwaheed@gmail.com.

No abstract available

Keywords: Aflibercept; Anti-VEGF; Diabetic macular edema; Diabetic retinopathy; OCT.